Publication

Byline

Singapore Clinical Trial: TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-label multicenter, Phase II study to assess the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) vs standard of care in patients with progressive metastatic castrate resistant prostate cancer

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-label... और पढ़ें


Singapore Clinical Trial: A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumour Activity of Novel Combinations in Participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (LIBRA)

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety,... और पढ़ें


Singapore Clinical Trial: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderate to Severe Hidradenitis Suppurativa

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety o... और पढ़ें


Singapore Clinical Trial: A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Parti... और पढ़ें


Singapore Clinical Trial: Prospective randomised controlled evaluation of Tetracycline ointment for preventing infections in uncomplicated soft-tissue wounds repaired in the emergency department – a pilot study.

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'Prospective randomised controlled evaluation of Tetracycline ointment for preventing infections in u... और पढ़ें


గురు గోచారం 2026: జూన్ 2 నుంచి కర్కాటకంలోకి బృహస్పతి.. ఈ 4 రాశుల జాతకం మారబోతోంది!

భారతదేశం, మే 9 -- ఖగోళంలో అతి పెద్ద గ్రహం, శుభ గ్రహంగా పిలిచే బృహస్పతి (గురుడు) తన రాశిని మార్చుకోబోతున్నాడు. జ్యోతిష్య శాస్త్రం ప్రకారం శని తర్వాత అంతటి ప్రభావం చూపే గ్రహం గురుడు మాత్రమే. ప్రస్తుతం మ... और पढ़ें


Singapore Clinical Trial: Responses Against Paramyxoviruses in T cells with crOss Reactivity

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'Responses Against Paramyxoviruses in T cells with crOss Reactivity'. The following are the other rel... और पढ़ें


Singapore Clinical Trial: Effect of innate immune reprogramming by primary dengue on host response to secondary dengue

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'Effect of innate immune reprogramming by primary dengue on host response to secondary dengue'. The f... और पढ़ें


Singapore Clinical Trial: Validation of Gore Test in patients with Sphincteric Dyssynergia presenting with Dysfunctional Voiding: A case controlled study

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'Validation of Gore Test in patients with Sphincteric Dyssynergia presenting with Dysfunctional Voidi... और पढ़ें


Singapore Clinical Trial: An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pembrolizumab versus chemotherapy alone in previously untreated locally advanced or metastatic urothelial cancer

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pembro... और पढ़ें